Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in France
Expanding vaccination recommendations for low-risk adults over 50 is cost-effective and represents a significant public health opportunity.
Authors
- Stéphane Simon (ORCID: https://orcid.org/0000-0003-3328-8111)
- Anne Mosnier (ORCID: https://orcid.org/0000-0002-3173-1186)
- Guillaume Béraud (ORCID: https://orcid.org/0000-0002-4705-0916)
- Paul Loubet (ORCID: https://orcid.org/0000-0002-1218-9432)
- Olivier Guérin (ORCID: https://orcid.org/0000-0001-7929-9081)
- Sandrine Gillet
- Quentin Berkovitch
- Henri Lesage
- Nathalie Cugnardey
- Justine Haond
- Pierre Gamblin
Institutions
- Université d'Orléans (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- MSD (France) (FR)
- Open Society (CZ)
- Institut de Recherche sur le Cancer et le Vieillissement de Nice (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Tris Pharma (United States) (US)
- Expertise Center Vocational Education (NL)
- Université de Nîmes (FR)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1007/s40121-025-01168-5
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35